6 Jun 2019 FDA AMDAC: Discussion of Pretomanid’s NDA for MDR-XDR TB
Dear All: FDA today posted a Federal Register announcement of an Antimicrobial Drugs Advisory Committee (AMDAC) meeting on 6 June 2019. The AMDAC will discuss pretomanid (formerly,
24 April 2019 No Comments